Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the study content and indicating that access to the record is blocked.SummaryDifference17%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a minor update to the page. This change does not modify study information or how the page operates for users.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new build. No study details or user-facing content appear to be altered.SummaryDifference0.1%

- Check103 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.